Skip to main content
. 2015 Aug 20;16:214. doi: 10.1186/s12891-015-0663-6

Table 1.

Results for outcomes: fatigue, pain, anxiety, depression, health distress, self-efficacy, and SF-36 at baseline, pre-intervention, post-intervention, 6- and 12-months follow up. Data are mean (SD)

Outcomes Baseline Pre-Ix Post-Ix 6 Months 12 Months
Fatigue (0–10) 6.1 (2.4) 5.7 (2.4) 5.1 (2.6)a 5.2 (2.7) 5.2 (2.9)
Pain (0–10) 5.1 (2.4) 4.9 (2.2) 4.8 (2.7) 4.9 (2.7) 4.4 (2.9)
Anxiety (0–21) 7.8 (4.1) 7.4 (3.9) 6.9 (3.9) 6.7 (4.0)a 6.7 (4.5)
Depression (0–21) 6.1 (3.8) 6.3 (4.3) 5.6 (3.9)a 5.2 (3.8)a 4.9 (3.9)a
Health distress (0–5) 2.3 (1.1)a 2.1 (1.1) 2.0 (1.0) 1.7 (1.2)a 1.4 (1.1)a
Self-efficacy (0–10) 5.5 (2.1)a 5.9 (1.9) 6.1 (2.1) 6.1 (2.3) 5.9 (2.8)
SF-36 (0–100)
Mental health 44.1 (10.6) 44.5 (11.1) 46.5 (9.5)a 47.2 (10.6)a 47.8 (10.9)a
Role emotional 40.5 (13.4) 41.5 (13.2) 42.6 (13.4) 45.3 (13.1)a 46.5 (11.8)a
Social function 39.6 (12.3)a 41.5 (12.1) 42.1 (11.1) 42.8 (13.1) 43.3 (11.9)
Vitality 38.8 (10.3)a 40.9 (10.9) 41.7 (10.4) 43.7 (11.5)a 43.7 (12.2)a
General health 39.3 (10.9) 40.2 (11.5) 39.3 (11.3) 41.0 (11.6) 41.5 (11.5)
Bodily pain 37.3 (7.2)a 38.9 (7.6) 38.8 (7.5) 39.8 (9.0) 40.6 (9.4)
Role physical 32.7 (10.2)a 35.0 (11.0) 36.2 (12.1) 39.3 (13.0)a 40.2 (12.1)a
Physical function 34.6 (11.0) 34.8 (11.5) 35.6 (11.3) 37.3 (11.4)a 38.6 (10.7)a

asignificantly different to pre-intervention (p < 0.05). Repeated measures ANOVA

Decreasing scores in fatigue, pain, anxiety, depression and health distress signify improvement, while increasing scores in self-efficacy and SF-36 signify improvement

Ix Intervention